|
February 2008 In the IDSA Journals Teaser here...Read More Europe Reports High Percentage of Oseltamivir-resistant Influenza Virus European health officials have reported finding oseltamivir resistance in a surprisingly high percentage of H1N1 influenza virus isolates tested so far this season....Read More
An Emerging Infections Network (EIN) member in Saudi Arabia asked whether he should attempt to decolonize a 53-year-old male patient with psoriasis carrying methicillin-resistant Staphylococcus aureus (MRSA). ...Read MoreMultidrug-resistant Staph Reported among MSM The Annals of Internal Medicine last month reported an outbreak of a multi-drug resistant strain of virulent Staphylococcus aureus among men who have sex with men in San Francisco and Boston....Read More Health Alerts, Drug Approvals, Recalls, Adverse Events ...Read More IDSA Policy & Advocacy Update: IDSA Opposes Anti-Thimerosal Legislation IDSA continues to advocate at the state level against legislation banning the use of thimerosal in vaccines due to unfounded concerns about its link to autism. ...Read More
A recent survey conducted by the Centers for Disease Control and Prevention (CDC) suggests that many primary care physicians (PCPs) prescribed amantadine and rimantadine last influenza season despite a warning about viral resistance. ...Read MoreThird Seasonal and Pandemic Influenza Meeting: May 18-20 Teaser here...Read More Meeting on Key Issues in TB Drug Development May 5 - 6, 2008, New Delhi, India ...Read More Welcome, New IDSA Members! ...Read More Calendar of Future Meetings and Events ...Read More CMS Requires NPI on Claims Starting March 1 Teaser here...Read More |
||
 |
||
Dates to RememberOct. 25-29, 2008 Oct. 29-Nov. 1, 2009
|
||||||||
 |
||||||||
|
